830
Views
5
CrossRef citations to date
0
Altmetric
Articles

U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients

, , , &
Pages 44-51 | Received 13 Jan 2020, Accepted 16 Jan 2020, Published online: 04 Feb 2020

References

  • Muiesan ML, Agabiti-Rosei C, Paini A, Salvetti M. Uric acid and cardiovascular disease: an update. Eur Cardiol. 2016;11:54–9. doi:10.15420/ecr.2016:4:2
  • Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 2009;61:225–32. doi:10.1002/art.24164
  • Zhang W, Iso H, Murakami Y, Miura K, Nagai M, Sugiyama D, et al. Serum uric acid and mortality form cardiovascular disease: EPOCH-JAPAN Study. J Atheroscler Thromb. 2016;23:1365–12. doi:10.5551/jat.Er31591
  • Cheong E, Ryu S, Lee JY, Lee SH, Sung JW, Cho DS, et al. Association between serum uric acid and cardiovascular mortality and all-cause mortality: a cohort study. J Hypertens. 2017;35:S3–S9. doi:10.1097/HJH.0000000000001330
  • Sakata K, Hashimoto T, Ueshima H, Okayama A. Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980–1994. Eur J Epidemiol. 2001;17:461–8.
  • Odden MC, Amadu AR, Smit E, Lo L, Peralta CA. Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988–1994 and 1999–2002. Am J Kidney Dis. 2014;64:550–7. doi:10.1053/j.ajkd.2014.04.024
  • Kang E, Hwang SS, Kim DK, Oh KH, Joo KW, Kim YS, et al. Sex-specific relationship of serum uric acid with all-cause mortality in adults with normal kidney function: an observational study. J Rheumatol. 2017;44:380–7. doi:10.3899/jrheum.160792
  • Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vardal M, Mjøen G, et al. Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients. Clin Transplant. 2014;28:134–40. doi:10.1111/ctr.12290
  • Cho SK, Chang Y, Kim I, Ryu S. U-shaped association between serum uric acid level and risk of mortality: a cohort study. Arthritis Rheumatol. 2018;70:1122–32. doi:10.1002/art.40472
  • Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308–20. doi:10.1001/jama.287.10.1308
  • Liu Q, Li D, Berger AE, Johns RA, Gao L. Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-Analysis. Sci Rep. 2017;7:1–10. doi:10.1038/s41598-017-12289-4
  • Zhu L, Wang J, Wang Y, Jia L, Sun K, Wang H, et al. Plasma uric acid as a prognostic marker in patients with hypertrophic cardiomyopathy. Can J Cardiol. 2015;31:1252–8. doi:10.1016/j.cjca.2015.02.018
  • Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79. doi:10.1093/eurheartj/ehu284
  • He S, Wang Z, Cheem TH, Liao H, Chen X, He Y. External validation of the model of thromboembolic risk in hypertrophic cardiomyopathy patients. Can J Cardiol. 2019;35:1800–6. doi:10.1016/j.cjca.2019.05.035
  • Wang Z, Liao H, He S, Chen X. Performance and validation of R-CHA2DS2VASc score for thromboembolism in patients with hypertrophic cardiomyopathy. Hellenic J Cardiol. 2019. [Epub ahead of print].
  • Manjunath G, Sarnak MJ, Levey AS. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens. 2001;10:785–92. doi:10.1097/00041552-200111000-00009
  • Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the Europe Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39. e14. doi:10.1016/j.echo.2014.10.003
  • Zhen H, Gui F. The role of hyperuricemia on vascular endothelium dysfunction. Biomed Rep. 2017;7:325–30. doi:10.3892/br.2017.966
  • Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41:1287–93. doi:10.1161/01.HYP.0000072820.07472.3B
  • Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, et al. Uric acid and inflammatory markers. Eur Heart J. 2006;27:1174–81. doi:10.1093/eurheartj/ehi879
  • Zhu L, Zou Y, Wang Y, Luo X, Wang H, Jia L, et al. Prognostic significance of plasma high-sensitivity C-reactive protein in patients with hypertrophic cardiomyopathy. JAMA. 2017;6:1–8.
  • Shah A, Keenan RT. Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?. Curr Rheumatol Rep. 2010;12:118–24. doi:10.1007/s11926-010-0084-3
  • Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A. The relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: molecular mechanisms and clinical implications. J Cardiol. 2012;59:235–42. doi:10.1016/j.jjcc.2012.01.013
  • Álvarez-Lario B, Macarrón-vicente J. Is there anything good in uric acid? Qjm. 2011;104:1015–24. doi:10.1093/qjmed/hcr159
  • Iso T, Kurabayashi M. Extremely low levels of serum uric acid are associated with endothelial dysfunction in humans. Circ J. 2015;79:978–80. doi:10.1253/circj.CJ-15-0232
  • Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971. JAMA. 2000;283:2404–10. doi:10.1001/jama.283.18.2404